205 related articles for article (PubMed ID: 38395893)
1. Metabolomic machine learning predictor for diagnosis and prognosis of gastric cancer.
Chen Y; Wang B; Zhao Y; Shao X; Wang M; Ma F; Yang L; Nie M; Jin P; Yao K; Song H; Lou S; Wang H; Yang T; Tian Y; Han P; Hu Z
Nat Commun; 2024 Feb; 15(1):1657. PubMed ID: 38395893
[TBL] [Abstract][Full Text] [Related]
2. Gastric Cancer Biomarker Candidates Identified by Machine Learning and Integrative Bioinformatics: Toward Personalized Medicine.
Sinnarasan VSP; Paul D; Das R; Venkatesan A
OMICS; 2023 Jun; 27(6):260-272. PubMed ID: 37229622
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
[No Abstract] [Full Text] [Related]
4. Identification and Validation of Plasma Metabolomic Signatures in Precancerous Gastric Lesions That Progress to Cancer.
Huang S; Guo Y; Li ZW; Shui G; Tian H; Li BW; Kadeerhan G; Li ZX; Li X; Zhang Y; Zhou T; You WC; Pan KF; Li WQ
JAMA Netw Open; 2021 Jun; 4(6):e2114186. PubMed ID: 34156450
[TBL] [Abstract][Full Text] [Related]
5. Targeted Metabolomic Profiling of Plasma Samples in Gastric Cancer by Liquid Chromatography-Mass Spectrometry.
Matsumoto T; Fukuzawa M; Itoi T; Sugimoto M; Aizawa Y; Sunamura M; Kawai T; Nemoto D; Shinohara H; Muramatsu T; Suzuki Y; Kagawa Y; Suguro M; Uchida K; Koyama Y; Madarame A; Morise T; Yamaguchi H; Sugimoto A; Yamauchi Y; Kono S; Naito S
Digestion; 2023; 104(2):97-108. PubMed ID: 36404717
[TBL] [Abstract][Full Text] [Related]
6. Modeling Epidemiology Data with Machine Learning Technique to Detect Risk Factors for Gastric Cancer.
Mohammadnezhad K; Sahebi MR; Alatab S; Sadjadi A
J Gastrointest Cancer; 2024 Mar; 55(1):287-296. PubMed ID: 37428282
[TBL] [Abstract][Full Text] [Related]
7. Plasma metabolome identifies potential biomarkers of gastric precancerous lesions and gastric cancer risk.
Li B; Shu X; Jiang H; Shi C; Qi L; Zhu L; Zhou J; Tang M; Hu A
Metabolomics; 2023 Aug; 19(8):73. PubMed ID: 37561286
[TBL] [Abstract][Full Text] [Related]
8. Circulating metabolites as potential biomarkers for the early detection and prognosis surveillance of gastrointestinal cancers.
Song G; Wang L; Tang J; Li H; Pang S; Li Y; Liu L; Hu J
Metabolomics; 2023 Apr; 19(4):36. PubMed ID: 37014438
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer survival prediction and biomarker identification with an ensemble machine learning analysis of tumor core biopsy metabolomic data.
Miller HA; van Berkel VH; Frieboes HB
Metabolomics; 2022 Jul; 18(8):57. PubMed ID: 35857204
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics study identified bile acids as potential biomarkers for gastric cancer: A case control study.
Pan C; Deng D; Wei T; Wu Z; Zhang B; Yuan Q; Liang G; Liu Y; Yin P
Front Endocrinol (Lausanne); 2022; 13():1039786. PubMed ID: 36465663
[TBL] [Abstract][Full Text] [Related]
11. Combining metabolome and clinical indicators with machine learning provides some promising diagnostic markers to precisely detect smear-positive/negative pulmonary tuberculosis.
Hu X; Wang J; Ju Y; Zhang X; Qimanguli W; Li C; Yue L; Tuohetaerbaike B; Li Y; Wen H; Zhang W; Chen C; Yang Y; Wang J; Chen F
BMC Infect Dis; 2022 Aug; 22(1):707. PubMed ID: 36008772
[TBL] [Abstract][Full Text] [Related]
12. Exosome Metabolic Patterns on Aptamer-Coupled Polymorphic Carbon for Precise Detection of Early Gastric Cancer.
Chen H; Huang C; Wu Y; Sun N; Deng C
ACS Nano; 2022 Aug; 16(8):12952-12963. PubMed ID: 35946596
[TBL] [Abstract][Full Text] [Related]
13. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
[TBL] [Abstract][Full Text] [Related]
14. Integration of transcriptomics, proteomics, and metabolomics data to reveal HER2-associated metabolic heterogeneity in gastric cancer with response to immunotherapy and neoadjuvant chemotherapy.
Yuan Q; Deng D; Pan C; Ren J; Wei T; Wu Z; Zhang B; Li S; Yin P; Shang D
Front Immunol; 2022; 13():951137. PubMed ID: 35990657
[TBL] [Abstract][Full Text] [Related]
15. Discriminating gastric cancer and gastric ulcer using human plasma amino acid metabolic profile.
Jing F; Hu X; Cao Y; Xu M; Wang Y; Jing Y; Hu X; Gao Y; Zhu Z
IUBMB Life; 2018 Jun; 70(6):553-562. PubMed ID: 29626382
[TBL] [Abstract][Full Text] [Related]
16. Metabolite biomarker discovery for human gastric cancer using dried blood spot mass spectrometry metabolomic approach.
Wu X; Ao H; Gao H; Zhu Z
Sci Rep; 2022 Aug; 12(1):14632. PubMed ID: 36030300
[TBL] [Abstract][Full Text] [Related]
17. Effect of metabolic reprogramming on the immune microenvironment in gastric cancer.
Shang Z; Ma Z; Wu E; Chen X; Tuo B; Li T; Liu X
Biomed Pharmacother; 2024 Jan; 170():116030. PubMed ID: 38128177
[TBL] [Abstract][Full Text] [Related]
18. A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer.
Lee IS; Ahn J; Kim K; Okugawa Y; Toiyama Y; Hur H; Goel A
Br J Cancer; 2021 Sep; 125(6):846-853. PubMed ID: 34163003
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a novel lysosomal signature for the diagnosis of gastric cancer with
Wang Q; Liu Y; Li Z; Tang Y; Long W; Xin H; Huang X; Zhou S; Wang L; Liang B; Li Z; Xu M
Front Immunol; 2023; 14():1182277. PubMed ID: 37215115
[TBL] [Abstract][Full Text] [Related]
20. Accurate diagnosis and prognosis prediction of gastric cancer using deep learning on digital pathological images: A retrospective multicentre study.
Huang B; Tian S; Zhan N; Ma J; Huang Z; Zhang C; Zhang H; Ming F; Liao F; Ji M; Zhang J; Liu Y; He P; Deng B; Hu J; Dong W
EBioMedicine; 2021 Nov; 73():103631. PubMed ID: 34678610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
